By Kashish Tandon (Reuters) -Indian drugmaker Anthem Biosciences' [ANTH.NS] $395 million IPO was fully subscribed on the second day of bidding on Tuesday, as investors bet on its growth prospects as ...

The initial public offering (IPO) of Anthem Biosciences was fully subscribed by the second day of bidding on Tuesday.The IPO ...

Anthem Biosciences IPO sees 20% GMP premium and strong subscriptions on Day 2; check allotment, listing, and key dates now!

Anthem Biosciences IPO got fully subscribed at 1.15 times on the second day of share sale on July 15. The initial share sale ...

The President of the United States was in attendance at the FIFA Club World Cup Final on Sunday. Chelsea took on PSG in the ...

Among investor categories, Non-Institutional Investors (NIIs) have shown the highest interest, bidding 1.55 times their ...

Indian drugmaker Anthem Biosciences' ANTH.NS $395 million public listing was fully subscribed on the second day of bidding, as investors bet on the company's growth prospects at a time when global big ...

There have been several notable national anthem performances over the years, with some being iconic and some being downright ...

MU Health Care said in a statement it has been in close communication with Anthem Monday but did not confirm whether the two ...

O'Laughlin has been pushing MU Health Care and Anthem to sign a deal since a June 30 Missouri Senate committee hearing over ...

Here's the latest on Ingrid Andress after her drunk rendition of the national anthem before the 2024 Home Run Derby.